CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Top Cited Papers
- 10 March 2011
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 11 (4) , 254-267
- https://doi.org/10.1038/nrc3023
Abstract
Can an abundantly expressed molecule be a reliable marker for the cancer-initiating cells (CICs; also known as cancer stem cells), which constitute the minority of cells within the mass of a tumour? CD44 has been implicated as a CIC marker in several malignancies of haematopoietic and epithelial origin. Is this a fortuitous coincidence owing to the widespread expression of the molecule or is CD44 expression advantageous as it fulfils some of the special properties that are displayed by CICs, such as self-renewal, niche preparation, epithelial-mesenchymal transition and resistance to apoptosis?Keywords
This publication has 190 references indexed in Scilit:
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human GlioblastomaPublished by Elsevier ,2010
- Complement activation on platelets: Implications for vascular inflammation and thrombosisMolecular Immunology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Identification and targeting of cancer stem cellsBioEssays, 2009
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 ExpressionPublished by Elsevier ,2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsPublished by Elsevier ,2008
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progressionPublished by Elsevier ,2008
- Alternative splicing in cancer: Noise, functional, or systematic?The International Journal of Biochemistry & Cell Biology, 2007
- Metastasis and stem cell pathwaysCancer and Metastasis Reviews, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006